Salbutamol Infusion for Premature Labour — The Australian Trials Experience
- 1 February 1981
- journal article
- clinical trial
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 21 (1) , 1-4
- https://doi.org/10.1111/j.1479-828x.1981.tb00113.x
Abstract
Summary: Fourteen clinical trials were conducted in Australia to evaluate the safety and efficacy of salbutamol infusions in the prevention of premature labour. A total of 527 single pregnancies and 36 multiple pregnancies during which this treatment was used were reported sufficiently fully for inclusion in this report. The results suggest that significant prolongation of pregnancy can be achieved in most cases, provided that cervical dilatation is less than 3 cm and that the membranes are intact. If either of these conditions is absent, prolongation of pregnancy is still possible in some cases.The treatment is not without risks, and adequate supervision is essential.Keywords
This publication has 12 references indexed in Scilit:
- APGAR SCORES, RESPIRATORY DISTRESS SYNDROME AND SALBUTAMOLThe Medical Journal of Australia, 1980
- Salbutamol in treatment of heart failure.Heart, 1980
- Premature LabourThe Medical Journal of Australia, 1979
- A comparison of salbutamol and ritodrine when used to inhibit premature labour complicated by ante-partum haemorrhage.Current Medical Research and Opinion, 1979
- THE EFFECT OF SALBUTAMOL AND TERBUTALINE IN THE MANAGEMENT OF PREMATURE LABOURActa Obstetricia et Gynecologica Scandinavica, 1977
- The Active Management of Pre‐term Labour and Its Effects on Fetal OutcomeAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1976
- THE TREATMENT OF PREMATURE LABOUR WITH INTRAVENOUSLY ADMINISTERED SALBUTAMOLThe Medical Journal of Australia, 1974
- Salbutamol and inhibition of uterine contractionsJournal of Pharmacy and Pharmacology, 1973
- INTRAVENOUS INFUSION OF SALBUTAMOL IN THE MANAGEMENT OF PREMATURE LABOURBJOG: An International Journal of Obstetrics and Gynaecology, 1973
- α-[(t-Butylamino)methyl]-4-hydroxy-m-xylene-α1, α3-diol (AH.3365): a Selective β-Adrenergic StimulantNature, 1968